Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -9.46
- Piotroski Score 5.00
- Grade Underperform
- Symbol (ACB)
- Company Aurora Cannabis Inc.
- Price $5.08
- Changes Percentage (-0.78%)
- Change -$0.04
- Day Low $5.05
- Day High $5.24
- Year High $9.35
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/06/2024
- Fiscal Year End N/A
- Average Stock Price Target $8.00
- High Stock Price Target $8.75
- Low Stock Price Target $1.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$57.91
- Trailing P/E Ratio -0.1
- Forward P/E Ratio -0.1
- P/E Growth -0.1
- Net Income $-69,326,000
Income Statement
Quarterly
Annual
Latest News of ACB
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Aurora Cannabis Inc (ACB) Q2 2025 Earnings Call Highlights: Record Growth in Medical Cannabis ...
Aurora Cannabis focuses on medical cannabis but maintains a small presence in the recreational market for insights and international readiness. With a strong financial position, they plan to invest in...
By Yahoo! Finance | 18 hours ago -
Aurora Cannabis (ACB) Q2 2025 Earnings Call Transcript
Aurora Cannabis had a strong Q2 with a focus on global medical cannabis markets. The company sees growth opportunities in Canada, Europe, and Australia. With a solid financial performance and strategi...
By Yahoo! Finance | 1 day ago -
Why Apple Was Forced To Upgrade The MacBook Air
Apple released three new MacBook Pro models with the latest M4 Silicon, emphasizing Apple Intelligence powered by Apple Silicon and Neural Engine. The MacBook Air now comes with 16 GB RAM instead of 8...
By Forbes | 5 days ago
